Association of HLA-DRw9 with myasthenia gravis in Chinese

J Immunogenet. 1987 Aug-Oct;14(4-5):203-7. doi: 10.1111/j.1744-313x.1987.tb00382.x.

Abstract

HLA phenotypes were studied in 59 Chinese myasthenia gravis (MG) patients. Unfractionated peripheral blood mononuclear cells were used for typing of HLA-A, B and C, and B-enriched lymphocytes for HLA-DR. Seventy-nine healthy subjects were included as controls. When compared with healthy controls, the patients showed significant increases in HLA-Bw46 (47.5% versus 14%, chi 2 = 18.7, P less than 0.001), HLA-DRw9 (59.3% versus 11%, chi 2 = 35.7, P less than 0.001), while HLA-DR3 was decreased (3.4% versus 32.9%, chi 2 = 18.2, P less than 0.001). Further analysis showed that the primary association was with DRw9 and the increase in Bw46 was secondary to it. Both HLA-Bw46 and -DRw9 were increased in all subgroups except where the age of onset was greater than 40 years. Finally, the HLA-A2-Bw46-DRw9 combination was also significantly increased in patients (25.4% versus 5.1%, chi 2 = 11.5, P less than 0.001), especially in the subgroups of MG with age of onset of less than 10 and males with age of onset of less than 40 years.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Child
  • China
  • Female
  • HLA Antigens / analysis
  • HLA-D Antigens / analysis*
  • HLA-DR Antigens / analysis*
  • HLA-DR Serological Subtypes
  • Humans
  • Male
  • Myasthenia Gravis / genetics*
  • Myasthenia Gravis / immunology

Substances

  • HLA Antigens
  • HLA-D Antigens
  • HLA-DR Antigens
  • HLA-DR Serological Subtypes
  • HLA-DR9 antigen